Plidenta Pro-t-action showed excellent results in clinical testing

Regular use of Plidenta Pro-t-action by a number of users with a very large amount of Streptococcus mutans bacteria, which is believed to be the most responsible for the appearance of cavities, decreased the amount of Streptococcus mutans significantly.

This is confirmed by clinical research results just published for the first time in the world for this toothpaste with a probiotic lactobacillus, which was conducted by two young Croatian scientists, doc.dr.sc. Dubravka Negovetić Vranić and prof.dr.sc. Martina Majstorović from the School of Dental Medicine at the University of Zagreb. According to the published results, the number of tested candidates who prior to using Plidenta Pro-t-action had a very large amount of cavity forming bacteria present in their saliva decreased significantly. After only 4 weeks of use of Plidenta’s toothpaste with the probiotic Lactobacillus paracasei bacteria, the number of tested candidates* with a very high number of streptococcus (≥10⁵) fell from 78.4% to 26.5%, and the number of tested candidates with a high number of lactobacillus (≥10⁵) fell from 52.9% to 26.5%.

“The research results conducted on this sample have suggested that regular daily use of Plidenta’s new toothpaste with probiotic bacteria, whose mechanism is based on selective removal of cariogenic bacteria, contributes to reducing the risk of caries. So this toothpaste represents the most innovative domestic product currently available on our toothpaste market, whose regular use can help achieve a significant effect in the prevention of cavities. It acts as an excellent therapeutic medium which leads to the optimal ratio of good and bad bacteria in the saliva which represents a significant innovation in preventive dentistry, especially in patients at high risk for cavities and with a large number of potentially pathogenic bacteria in their mouths,” concluded doc.dr.sc.Dubravka Negovetić Vranić and prof.dr.sc. Martina Majstorović in their research project.

Lactobacillus Pro-t-action is a revolutionary innovation of the German BASF Future Business GmbH company, developed from probiotic cultures of the L. paracasei bacteria. The special characteristic of Pro-t-action is that it reacts only with the cavity-causing bacteria, and it does not affect the number of other bacteria in the mouth. According to the recent studies presented at international conferences, Lactobacillus pro-t-action reduces the number of S. mutans bacteria, the most responsible pathogens in forming cavities, to even up to 50% if used daily. The new toothpaste was developed by the experts in Neva, an Atlantic Group member, as the first toothpaste in the world to contain this probiotic culture. The clinical testing conducted by doc.dr.sc. Dubravka Negovetić Vranić and prof.dr.sc. Martina Majstorović was the first such testing of a toothpaste with the probiotic Lactobacillus paracasei bacteria in the world. The Ministry of Health and Social Welfare of the Republic of Croatia listed Plidenta Pro-t-action toothpaste as a special use cosmetics.

The efficiency of Plidenta Pro-t-action toothpaste was tested on 50 healthy candidates aged between 20 and 24 years, who voluntarily participated in this study. Over the course of 4 weeks, the candidates used only Plidenta Pro-t-action toothpaste and Plidenta Expert Medium toothbrush with medium-hard bristles.